Lipid Management in Diabetes – Japanese
This infographic provides guidance for treating people with type 2 diabetes who are at risk for ASCVD.
Also available in English, Spanish, Chinese and Portuguese.
Cardiovascular Disease Risk Reduction in Type 2 Diabetes – Japanese
This infographic provides guidance on reducing cardiovascular disease risk for people with type 2 diabetes.
Also available in English, Spanish, Chinese and Portuguese.
Lipid Management in Diabetes – Chinese
This infographic provides guidance for treating people with type 2 diabetes who are at risk for ASCVD.
Also available in English, Spanish, Japanese, and Portuguese.
Lipid Management in Diabetes – Spanish
This infographic provides guidance for treating people with type 2 diabetes who are at risk for ASCVD.
Also available in English, Chinese, Japanese and Portuguese.
Cardiovascular Disease Risk Reduction in Type 2 Diabetes – Chinese
This infographic provides guidance on reducing cardiovascular disease risk for people with type 2 diabetes.
Also available in English, Spanish, Japanese and Portuguese.
Cardiovascular Disease Risk Reduction in Type 2 Diabetes – Spanish
This infographic provides guidance on reducing cardiovascular disease risk for people with type 2 diabetes.
Also available in English, Chinese, Japanese, and Portuguese.
84th Scientific Sessions Recap Videos—Latest Research on CVD and Diabetes
Panel Discussion – A Multidisciplinary Approach—Challenging Cases from the Cardiometabolic Clinic
Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP
Allen I. White Distinguished Professor, Department of Pharmacotherapy
College of Pharmacy and Pharmaceutical Sciences, Washington State University
Discussion on Diabetes and Cardiovascular Disease—Obesity and Diabetes—Innovative Research to Inform Clinical Practice
Dr. Tracey Taveira, PharmD, CDOE
University of Rhode Island
SELECT Trial—New Looks at Glycemia, Inflammation, and Heart Failure
Mark D. Benson, M.D., Ph.D.
Director of Preventive Cardiology at Beth Israel Deaconess Medical Center (BIDMC)
THE STEP-HFpEF and STEP-HFpEF-DM Trials—Targeting Obesity to Treat Heart Failure
Vanita Aroda, M.D.
Director of Diabetes Clinical Research at Brigham and Women’s Hospital
Assoc. Dir. Medicine at Harvard Medical School
Cardiovascular Disease in Type 2 Diabetes Advanced Course
The Know Diabetes by Heart™ Cardiovascular Disease in Type 2 Diabetes Advanced Course provides the latest lifestyle and pharmacotherapy guidelines for cardiorenal metabolic disease management.
This is a FREE, four-part online course you can take at your own pace to learn how to unlock better health outcomes for people living with type 2 diabetes and cardiovascular disease.
During this course you will:
- Elevate your expertise in cardiorenal and metabolic management.
- Learn current lifestyle and pharmacotherapy guidelines for treating people with type 2 diabetes and atherosclerotic cardiovascular disease, heart failure, and/or chronic kidney disease.
- Understand how to develop management plans with individual- and medication-specific considerations using realistic case studies.
Developed from the Standards of Care in Diabetes—2024 and utilizing the most current science-based content for cardiologists, nephrologists, and endocrinologists, this course will equip you with knowledge to minimize cardiovascular and cardiorenal disease and optimize glycemic management for the people you see.
Use of Glucose-Lowering Medications in the Management of Type 2 Diabetes
Watch the Video
Know Diabetes By Heart Toolkit
The Know Diabetes by Heart Toolkit is a collection of interactive resources for health care professionals to help patients with type 2 diabetes commit to a healthy lifestyle and take action to lower their risk of complications and live their best lives.
